Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun;49(3):169-180.
doi: 10.1111/iji.12574. Epub 2022 Apr 29.

Association study of TAP and HLA-I gene combination with chronic hepatitis C virus infection in a Han population in China

Affiliations

Association study of TAP and HLA-I gene combination with chronic hepatitis C virus infection in a Han population in China

Yufen Tao et al. Int J Immunogenet. 2022 Jun.

Abstract

Host immune system genes play key roles in the progression of chronic hepatitis C virus (HCV) infection. Transporters associated with antigen processing (TAP) play an important role in the loading of viral peptides onto MHC class I molecules. This study aimed to investigate the association between TAP gene polymorphisms and chronic HCV in a Chinese Han population. A total of 232 chronic hepatitis C (CHC) patients and 362 healthy individuals were recruited from the Han population in Yunnan province in southwest China, and a TaqMan SNP genotyping assay was used to detect six single nucleotide polymorphisms (SNPs) of TAP1 and three SNPs of TAP2 genes. The association of the TAP gene with CHC was analysed at the allele, genotype, and haplotype levels. There were no significant differences in the allele and genotype frequencies of these SNPs in the TAP gene between CHC patients and controls after Bonferroni correction. A novel TAP1 allele (TAP1*unknown_1: rs41555220-rs41549617-rs1057141-rs1135216-rs1057149-rs41551515: G-G-A-G-G-G) was only present in the CHC group, and this allele significantly increased susceptibility to CHC (p = .005, odds ratio [OR] = 11.105. 95% confidence interval [CI]: 1.362-90.558). Homozygous TAP1*03:01/TAP1*03:01 was observed only in the CHC group that exhibited an obvious risk for CHC (p = .002, OR = 9.637, 95% CI: 1.153-80.574). And the haplotype TAP1*unknown_1-TAP2*01:01 was only present in the CHC group and indicated a significant risk for CHC (p = .002, OR = 9.498, 95% CI: 1.140-79.149). We observed significant interactions among HLA-A, -B,C, TAP1, and TAP2 alleles, and combination analysis revealed that the combination of TAP1*01:01-TAP2*01:01-HLA-B*35:01 was only present in the control group (2.2%) and resulted in significantly increased resistance to CHC (p = .002, OR = 0.096, 95% CI: 0.012-0.759). Whereas, the combination of TAP1*01:01-TAP2*01:01-HLA-C*07:02 and TAP1*03:01-TAP2*01:01-HLA-C*01:02 increased the susceptibility to CHC significantly (p = .001, OR = 2.016, 95% CI: 1.309-3.106 and p = .002, OR = 8.070, 95% CI: 1.018-63.997, respectively). Our results indicated that TAP and HLA-I may exert a combined effect on CHC susceptibility in the Chinese Han population.

Keywords: HLA class I; Han Chinese; TAP1 and TAP2; chronic hepatitis C infection; polymorphisms.

PubMed Disclaimer

Similar articles

References

REFERENCES

    1. Beismann-Driemeyer, S., & Tampe, R. (2004). Function of the antigen transport complex TAP in cellular immunity. Angewandte Chemie (International ed in English), 43(31), 4014-4031. https://doi.org/10.1002/anie.200300642
    1. Cazarez-Navarro, G., Palomares-Marín, J., Rodríguez-Preciado, S. Y., Pereira-Suárez, A. L., Martínez-López, E., Bacilio-Medrano, E. A., Huerta-Olvera, S., & Hernández, C. II (2021). Association of TAP1 1177A>G and 2090A>G gene polymorphisms with latent tuberculosis infections in sheltered populations, in the metropolitan area of Guadalajara, Mexico: A pilot study. Revista Do Instituto De Medicina Tropical De Sao Paulo, 63, e55. https://doi.org/10.1590/s1678-9946202163055
    1. Chinese Society of Hepatology, C. M. A. C. S. o. I. D., Chinese Medical Association. (2019). Guidelines for the prevention and treatment of chronic hepatitis C (2019 version). Journal of Clinical Hepatology, 35(12), 2670-2686.
    1. Cui, Q., Zhang, Y., Su, J., Shi, C., Lei, N., Ding, K., Li, J., Yu, R., Wang, L., & Wang, N. (2010). The association between the genetic polymorphisms of LMP2/LMP7 and the outcomes of HCV infection among drug users. The Journal of Biomedical Research, 24(5), 374-380. https://doi.org/10.1016/S1674-8301(10)60050-4
    1. Feng, M. L., Yin, B., Shen, T., Ma, Q., Liu, L., Zheng, J., Zhao, Y., Qian, K., & Liu, D. (2009). TAP1 and TAP2 polymorphisms associated with ankylosing spondylitis in genetically homogenous Chinese Han population. Human Immunology, 70(4), 257-261. https://doi.org/10.1016/j.humimm.2009.01.028

MeSH terms

Substances

LinkOut - more resources